ArticlePediatric research2026
Comparison of Crohn's disease exclusion diet and exclusive enteral nutrition in prospectively followed paediatric patients with Crohn's disease.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors Affecting the Adherence to Partial Enteral Nutrition Combined with the Crohn's Disease Exclusion Diet in Crohn's Disease Adult Patients.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrohn's Disease exclusion diet (CDED) has been associated with positive outcomes in paediatric Crohn's disease (CD) remission induction. This study prospectively compared clinical outcomes of CDED versus exclusive enteral nutrition (EEN).
methodsCDED was implemented in January 2020 for induction in newly diagnosed CD patients with paediatric CD activity index (PCDAI) ≤ 40. Children induced with EEN (2014-2017) were included as a reference group. Clinical response (PCDAI decrease of 12.5 or <10 points) and mucosal healing (MINI index <8 points) were primary outcomes prospectively assessed in week 6. The secondary outcome, clinical relapse within the first year, was defined as therapy change or two consecutive fecal calprotectin levels >500 µg/g.
resultsThis study included 66 patients, 33 in each group, with significantly higher baseline PCDAI in the EEN group. Clinical response, observed in 76% of children on CDED and 82% receiving EEN, yielded aOR of 0.56 (95% CI = 0.08-3.50) for CDED vs EEN. Mucosal healing, achieved in 48% of children on CDED and 33% of EEN patients, was not associated with induction type (aOR = 1.74 [95% CI = 0.51-6.13]). CDED was associated with lower relapse risk (HR = 0.56 [95% CI = 0.32-0.99]); did not remain after adjustment.
conclusionCDED was not associated with less favourable clinical outcomes compared to EEN induction. IMPACT: Exclusive enteral nutrition (EEN) is a well-established induction therapy for children with mild to moderate Crohn's disease (CD), with tolerance representing one of its main limitations. In this prospective comparison of Crohn´s Disease Exclusion Diet (CDED) and EEN in newly diagnosed paediatric patients, CDED was not associated with significantly worse clinical outcomes compared to EEN. In routine clinical practice, CDED appears to be a suitable induction treatment option for children with mild to moderate CD, with outcomes comparable to EEN.
Identifiers
42399683What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.